CHARACTERIZATION OF ACUTE MYELOGENOUS LEUKEMIA STEM CELL

急性髓性白血病干细胞的表征

基本信息

  • 批准号:
    3446987
  • 负责人:
  • 金额:
    $ 5.26万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1986
  • 资助国家:
    美国
  • 起止时间:
    1986-07-01 至 1990-03-31
  • 项目状态:
    已结题

项目摘要

This project involves the study of the leukemia-colony forming cell population (L-CFC) in patients with acute myelogenous leukemia (AML). In one aspect of this study, the cell surface antigens expressed by the L-CFC will be examined in patients with AML using a panel of myeloid-specific monoclonal antibodies and complement-mediated cytotoxicity. Patients will be examined serially on subsequent relapses to determine whether the L-CFC phenotype is stable with time. The findings from these studies will then be compared to a series of experiments designed to examine the inducibility to maturation of the L-CFC using various agents known to effect myeloid cell differentiation. The agents to be tested include recombinant gamma interferon, 1,25 dihydroxyvitamin D3, and cis-retinoic acid. Changes in surface antigens, proliferative potential, and morphology will be examined in the L-CFC exposed to optimal concentrations of the maturation-inducing agents. The studies are designed to examine whether the L-CFC in AML is responsive to agents of differentiation, and to determine whether response is manifested in cellular changes similar to those of normal myelopoiesis (i.e., expression of a more differentiated cell phenotype and a reduction in cellular proliferation). Another aspect is to correlate the cell surface antigenic display of both normal and leukemic myeloid cells with oncogene expression. The expression of three myeloid-associated cellular oncogenes (c-onc) will be studied: N-ras, c-myc and c-fos. Oncogene expression will be quantified by hybridization of probes to c-onc RNA extracted from normal myeloid subpopulations (monocytes and neutrophils) and from leukemia blast cell populations from patients with AML. Expression of oncogene protein products will be determined by immunofluorescence studies using antisera to the oncogene proteins, and by immunoprecipitation studies of radiolabelled cell lysates. The aim of these studies is to correlate the expression of oncogenes with patterns of myeloid cell-surface antigens on normal and malignant cells to determine whether there is a relationship with differentiation status. Results will further our understanding of leukemia cell biology in AML, and are directed towards clarifying the maturational defect that occurs in myelogenous leukemia. By determining the maturational capabilities of the L-CFC population, alternative approaches to therapy, including immunotherapy and maturation-inducing therapy, may result.
这个项目涉及白血病集落形成细胞的研究

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Monoclonal antibodies to carbohydrate antigens in autologous bone marrow transplantation.
自体骨髓移植中针对碳水化合物抗原的单克隆抗体。
Distribution of the 124-kd antigen defined by monoclonal antibody AML-1-99 on normal and leukemic myeloid cells.
单克隆抗体 AML-1-99 定义的 124-kd 抗原在正常和白血病骨髓细胞上的分布。
  • DOI:
  • 发表时间:
    1988
  • 期刊:
  • 影响因子:
    2.6
  • 作者:
    Howell,AL;Miller,R;Keefe,KA;McIntyre,OR;Stockner,M;Sullivan,R;Hibbert,SR;Noelle,RJ;Ball,ED
  • 通讯作者:
    Ball,ED
Induction of differentiation in blast cells and leukemia colony-forming cells from patients with acute myeloid leukemia.
急性髓性白血病患者的母细胞和白血病集落形成细胞的分化诱导。
  • DOI:
  • 发表时间:
    1990
  • 期刊:
  • 影响因子:
    20.3
  • 作者:
    Howell,AL;Stukel,TA;Bloomfield,CD;Davey,FR;Ball,ED
  • 通讯作者:
    Ball,ED
Gamma interferon and 1,25 dihydroxyvitamin D3 cooperate in the induction of monocytoid differentiation but not in the functional activation of the HL-60 promyelocytic leukemia cell line.
γ 干扰素和 1,25 二羟基维生素 D3 共同诱导单核细胞分化,但不参与 HL-60 早幼粒细胞白血病细胞系的功能激活。
  • DOI:
  • 发表时间:
    1986
  • 期刊:
  • 影响因子:
    2.6
  • 作者:
    Ball,ED;Howell,AL;Shen,L
  • 通讯作者:
    Shen,L
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ALEXANDRA L HOWELL其他文献

ALEXANDRA L HOWELL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ALEXANDRA L HOWELL', 18)}}的其他基金

Developing novel CRISPR/CasX editors to generate a CCR5/null immune system
开发新型 CRISPR/CasX 编辑器以生成 CCR5/null 免疫系统
  • 批准号:
    10553152
  • 财政年份:
    2021
  • 资助金额:
    $ 5.26万
  • 项目类别:
Developing novel CRISPR/CasX editors to generate a CCR5/null immune system
开发新型 CRISPR/CasX 编辑器以生成 CCR5/null 免疫系统
  • 批准号:
    10356091
  • 财政年份:
    2021
  • 资助金额:
    $ 5.26万
  • 项目类别:
Combination Therapy Using CRISPR/Cas Gene Editing Plus Human Monoclonal Antibodies for a Functional HIV Cure
使用 CRISPR/Cas 基因编辑加人单克隆抗体的联合疗法实现功能性 HIV 治愈
  • 批准号:
    9032718
  • 财政年份:
    2015
  • 资助金额:
    $ 5.26万
  • 项目类别:
Inhibiting Mucosal HIV-1 Transmission by Host Cell RNA Interference
通过宿主细胞 RNA 干扰抑制粘膜 HIV-1 传播
  • 批准号:
    7910642
  • 财政年份:
    2009
  • 资助金额:
    $ 5.26万
  • 项目类别:
Inhibiting Mucosal HIV-1 Transmission by Host Cell RNA Interference
通过宿主细胞 RNA 干扰抑制粘膜 HIV-1 传播
  • 批准号:
    7788891
  • 财政年份:
    2009
  • 资助金额:
    $ 5.26万
  • 项目类别:
Inhibiting Mucosal HIV-1 Transmission by Host Cell RNA Interference
通过宿主细胞 RNA 干扰抑制粘膜 HIV-1 传播
  • 批准号:
    8391122
  • 财政年份:
    2009
  • 资助金额:
    $ 5.26万
  • 项目类别:
Inhibiting Mucosal HIV-1 Transmission by Host Cell RNA Interference
通过宿主细胞 RNA 干扰抑制粘膜 HIV-1 传播
  • 批准号:
    8195248
  • 财政年份:
    2009
  • 资助金额:
    $ 5.26万
  • 项目类别:
CHARACTERIZATION OF ACUTE MYELOGENOUS LEUKEMIA STEM CELL
急性髓性白血病干细胞的表征
  • 批准号:
    3446985
  • 财政年份:
    1986
  • 资助金额:
    $ 5.26万
  • 项目类别:
CHARACTERIZATION OF ACUTE MYELOGENOUS LEUKEMIA STEM CELL
急性髓性白血病干细胞的表征
  • 批准号:
    3446986
  • 财政年份:
    1986
  • 资助金额:
    $ 5.26万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了